These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29955370)

  • 1. TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus.
    Idborg H; Eketjäll S; Pettersson S; Gustafsson JT; Zickert A; Kvarnström M; Oke V; Jakobsson PJ; Gunnarsson I; Svenungsson E
    Lupus Sci Med; 2018; 5(1):e000260. PubMed ID: 29955370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Principal component analysis reveals disconnect between regulatory cytokines and disease activity in Systemic Lupus Erythematosus.
    Raymond WD; Eilertsen GØ; Nossent J
    Cytokine; 2019 Feb; 114():67-73. PubMed ID: 30551949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory markers in saliva and urine reflect disease activity in patients with systemic lupus erythematosus.
    Ruacho G; Lira-Junior R; Gunnarsson I; Svenungsson E; Boström EA
    Lupus Sci Med; 2022 Mar; 9(1):. PubMed ID: 35246487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quick Systemic Lupus Activity Questionnaire (Q-SLAQ): a simplified version of SLAQ for patient-reported disease activity.
    Svenungsson E; Gunnarsson I; Illescas-Bäckelin V; Trysberg E; Jönsen A; Leonard D; Sjöwall C; Pettersson S
    Lupus Sci Med; 2021 May; 8(1):. PubMed ID: 33972457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and urine interleukin-17A levels as biomarkers of disease activity in systemic lupus erythematosus.
    Nordin F; Shaharir SS; Abdul Wahab A; Mustafar R; Abdul Gafor AH; Mohamed Said MS; Rajalingham S; Shah SA
    Int J Rheum Dis; 2019 Aug; 22(8):1419-1426. PubMed ID: 31179646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
    Wais T; Fierz W; Stoll T; Villiger PM
    J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between levels of TNF-alpha and IL-6 and hematological involvement in SLE Egyptian patients with lupus nephritis.
    Sabry A; Elbasyouni SR; Sheashaa HA; Alhusseini AA; Mahmoud K; George SK; Kaleek EA; abo-Zena H; Kalil AM; Mohsen T; Rahim MA; El-samanody AZ
    Int Urol Nephrol; 2006; 38(3-4):731-7. PubMed ID: 17260180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus.
    Enocsson H; Wetterö J; Eloranta ML; Gullstrand B; Svanberg C; Larsson M; Bengtsson AA; Rönnblom L; Sjöwall C
    Front Immunol; 2021; 12():688753. PubMed ID: 34276678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity.
    Sabry A; Sheashaa H; El-Husseini A; Mahmoud K; Eldahshan KF; George SK; Abdel-Khalek E; El-Shafey EM; Abo-Zenah H
    Cytokine; 2006 Aug; 35(3-4):148-53. PubMed ID: 17027280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum IP-10 is useful for identifying renal and overall disease activity in pediatric systemic lupus erythematosus.
    Zhang CX; Cai L; Shao K; Wu J; Zhou W; Cao LF; Chen TX
    Pediatr Nephrol; 2018 May; 33(5):837-845. PubMed ID: 29264699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of IL-34, IFN-α and IFN-λ1 on activity of systemic lupus erythematosus in Egyptian patients.
    Adel Y; Sadeq Y
    Reumatologia; 2020; 58(4):221-230. PubMed ID: 32921829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of patients' and physicians' assessments of disease activity using the Swedish version of the Systemic Lupus Activity Questionnaire.
    Pettersson S; Svenungsson E; Gustafsson J; Möller S; Gunnarsson I; Welin Henriksson E
    Scand J Rheumatol; 2017 Nov; 46(6):474-483. PubMed ID: 28293972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum interleukin-2 receptor
    Tian JY; Zhang X; Cheng G; Liu QH; Wang SY; He J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1083-1087. PubMed ID: 34916686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-γ Is Associated with Cerebral Atrophy in Systemic Lupus Erythematosus.
    Postal M; Ruocco HH; Brandão CO; Costallat LTL; Silva L; Cendes F; Appenzeller S
    Neuroimmunomodulation; 2017; 24(2):100-105. PubMed ID: 28848179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic Lupus Erythmatosus is Associated with Disturbed Cytokine Milieu and Increased TNF-Related Apoptosis-Induced Ligand Levels.
    Saeed AM; Mogahed MM
    Egypt J Immunol; 2016 Jun; 23(2):75-85. PubMed ID: 28502135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Levels of T Cell Immunoglobulin and Mucin-Domain Containing Molecule 3 in Patients with Systemic Lupus Erythematosus.
    Asano T; Matsuoka N; Fujita Y; Matsumoto H; Temmoku J; Yashiro-Furuya M; Sato S; Suzuki E; Kobayashi H; Watanabe H; Migita K
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33167436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
    Ward MM; Marx AS; Barry NN
    J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?
    Gómez D; Correa PA; Gómez LM; Cadena J; Molina JF; Anaya JM
    Semin Arthritis Rheum; 2004 Jun; 33(6):404-13. PubMed ID: 15190525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.